Piperacillin/tazobactam versus Carbapenems in Patients with Severe Bacterial Infections: A Systematic Review with Meta-analysis.
Marie Warrer MunchAnders GranholmAndreas Bender JonssonFredrik SjövallMarie HellebergFrederik Boetius HertzJakob Steen AndersenMorten SteensenMichael Patrick AchiamAnders PernerMorten Hylander MøllerPublished in: Acta anaesthesiologica Scandinavica (2023)
Based on very low or low certainty evidence, piperacillin/tazobactam may be associated with less favourable outcomes in patients with severe bacterial infections as compared with carbapenems, but the information size for a robust conclusion has not been reached. This article is protected by copyright. All rights reserved.